Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 1 1

Status

Recruiting 3Completed 3

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 5Myeloid 5Lymphoid 5Gastrointestinal 3Tumor-Agnostic 2Dermatologic 2Thoracic 1Head & Neck 1Classical hematology 1CNS 1Breast 1

Conditions

Liver Neoplasms 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma, Hepatocellular 1

Interventions

Fluorouracil 616Oxaliplatin 579Gemcitabine 492Capecitabine 445Leucovorin 427Irinotecan 390Bevacizumab 330Cisplatin 320Radiotherapy 245Cetuximab 215Sorafenib 167pembrolizumab 150Docetaxel 150Paclitaxel 140Nivolumab 128Albumin-Bound Paclitaxel 108130-nm albumin-bound paclitaxel 108Folfox protocol 101Panitumumab 95Erlotinib Hydrochloride 95Surgical Procedures, Operative 86regorafenib 84S 1 (combination) 81Drug Therapy 80Radiation 69Carboplatin 65Neoadjuvant Therapy 64Colonoscopy 64Radiosurgery 62Surveys and Questionnaires 60

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Antibodies × Gastrointestinal × Clear all
NCT00199862 2025-07-04

Safety Study of Radio-labeled huA33 Antibody in Colorectal Cancer

Memorial Sloan Kettering Cancer Center

Phase NA Completed
30 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT04618367 2024-03-06

HAIC Combined With Lenvatinib and Sintilimab for Hepatocellular Carcinoma With PVTT

Sun Yat-sen University

Phase NA Completed
30 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT01765790 2021-05-05

Phase 1 Study of Anti-Macrophage Migration Inhibitory Factor (Anti-MIF) Antibody in Solid Tumors

Takeda

Phase 1 Completed
68 enrolled
Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡